Adherence to Therapy in Glaucoma Treatment-A Review

Overview

Journal J Pers Med

Date 2022 Apr 23

PMID 35455630

Authors

Alexandra-Catalina Zaharia

Otilia-Maria Dumitrescu

Madalina Radu

Roxana-Elena Rogoz

Affiliations

Soon will be listed here.

Abstract

Glaucoma is a chronic disease and the second leading cause of irreversible vision loss worldwide, whose initial treatment consists of self-administered topical ocular hypotensive eyedrops. Adherence with glaucoma medications is a fundamental problem in the care of glaucoma patients as up to 50% of patients fail to receive the intended benefits of the treatment. The literature has identified many barriers to patients' compliance, from factors depending on the type of medication administered, communication between physician and patients, to factors dependent on patients' behaviour and lifestyle. Failure to take medication as prescribed increases the risk that patients will not receive the desired benefit, which often leads to a worsening of the disease. Our aim is to synthesize the methods used for measuring adherence of patients to glaucoma therapy and the interventions used for addressing adherence, laying emphasis on a patient-centred approach, taking time to educate patients about their chronic disease and to assess their views on treatment.

Citing Articles

Association of arterial stiffness and eye disease: a systematic review and meta-analysis.

Beros A, Sluyter J, Scragg R BMJ Open Ophthalmol. 2025; 10(1).

PMID: 39855645 PMC: 11759874. DOI: 10.1136/bmjophth-2024-001980.

The Role of Adjunctive Triamcinolone Acetonide in Post-traumatic Vitreoretinal Surgery: Current Insights and Future Perspectives.

Gandhi A, Daigavane S Cureus. 2024; 16(10):e71040.

PMID: 39525235 PMC: 11543381. DOI: 10.7759/cureus.71040.

Impact of Sociodemographic and Psychological Factors on Adherence to Glaucoma Treatment - A Cross-Sectional Study.

Malewicz K, Pender A, Chabowski M, Jankowska-Polanska B Clin Ophthalmol. 2024; 18:2503-2520.

PMID: 39246554 PMC: 11380480. DOI: 10.2147/OPTH.S475812.

Initial Clinical Experience with Ahmed Valve in Romania: Five-Year Patient Follow-Up and Outcomes.

Barac R, Harghel V, Anton N, Balta G, Tofolean I, Dragosloveanu C Bioengineering (Basel). 2024; 11(8).

PMID: 39199778 PMC: 11351579. DOI: 10.3390/bioengineering11080820.

The Role and Mechanism of Nicotinamide Riboside in Oxidative Damage and a Fibrosis Model of Trabecular Meshwork Cells.

Zeng Y, Lin Y, Yang J, Wang X, Zhu Y, Zhou B Transl Vis Sci Technol. 2024; 13(3):24.

PMID: 38546981 PMC: 10981432. DOI: 10.1167/tvst.13.3.24.

References

Ahmed R, Aslani P . What is patient adherence? A terminology overview. Int J Clin Pharm. 2013; 36(1):4-7. DOI: 10.1007/s11096-013-9856-y. View

Stewart W, Konstas A, Pfeiffer N . Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocul Pharmacol Ther. 2005; 20(6):461-9. DOI: 10.1089/jop.2004.20.461. View

Robin A, Novack G, Covert D, Crockett R, Marcic T . Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. Am J Ophthalmol. 2007; 144(4):533-40. DOI: 10.1016/j.ajo.2007.06.012. View

Quaranta L, Riva I, Gerardi C, Oddone F, Floriani I, Konstas A . Quality of Life in Glaucoma: A Review of the Literature. Adv Ther. 2016; 33(6):959-81. PMC: 4920851. DOI: 10.1007/s12325-016-0333-6. View

Newman-Casey P, Salman M, Lee P, Gatwood J . Cost-Utility Analysis of Glaucoma Medication Adherence. Ophthalmology. 2019; 127(5):589-598. PMC: 7145750. DOI: 10.1016/j.ophtha.2019.09.041. View

Lacey J, Cate H, Broadway D . Barriers to adherence with glaucoma medications: a qualitative research study. Eye (Lond). 2008; 23(4):924-32. DOI: 10.1038/eye.2008.103. View

Slota C, Davis S, Blalock S, Carpenter D, Muir K, Robin A . Patient-Physician Communication on Medication Cost during Glaucoma Visits. Optom Vis Sci. 2017; 94(12):1095-1101. PMC: 5726412. DOI: 10.1097/OPX.0000000000001139. View

Hoevenaars J, Schouten J, van den Borne B, Beckers H, Webers C . Will improvement of knowledge lead to improvement of compliance with glaucoma medication?. Acta Ophthalmol. 2008; 86(8):849-55. DOI: 10.1111/j.1755-3768.2007.01161.x. View

Stevenson F, Cox K, Britten N, Dundar Y . A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect. 2004; 7(3):235-45. PMC: 5060245. DOI: 10.1111/j.1369-7625.2004.00281.x. View

10.

Windham B, Griswold M, Fried L, Rubin G, Xue Q, Carlson M . Impaired vision and the ability to take medications. J Am Geriatr Soc. 2005; 53(7):1179-90. DOI: 10.1111/j.1532-5415.2005.53376.x. View

11.

Tataru C, Tataru C, Costache A, Boruga O, Zemba M, Ciuluvica R . Congenital cataract - clinical and morphological aspects. Rom J Morphol Embryol. 2020; 61(1):105-112. PMC: 7728133. DOI: 10.47162/RJME.61.1.11. View

12.

Gelb L, Friedman D, Quigley H, Lyon D, Tan J, Kim E . Physician beliefs and behaviors related to glaucoma treatment adherence: the Glaucoma Adherence and Persistency Study. J Glaucoma. 2008; 17(8):690-8. DOI: 10.1097/IJG.0b013e31816b3001. View

13.

Hahn S . Patient-centered communication to assess and enhance patient adherence to glaucoma medication. Ophthalmology. 2009; 116(11 Suppl):S37-42. DOI: 10.1016/j.ophtha.2009.06.023. View

14.

Rajurkar K, Dubey S, Gupta P, John D, Chauhan L . Compliance to topical anti-glaucoma medications among patients at a tertiary hospital in North India. J Curr Ophthalmol. 2018; 30(2):125-129. PMC: 6033778. DOI: 10.1016/j.joco.2017.09.002. View

15.

Robin A, Grover D . Compliance and adherence in glaucoma management. Indian J Ophthalmol. 2010; 59 Suppl:S93-6. PMC: 3038505. DOI: 10.4103/0301-4738.73693. View

16.

Sleath B, Blalock S, Carpenter D, Sayner R, Muir K, Slota C . Ophthalmologist-patient communication, self-efficacy, and glaucoma medication adherence. Ophthalmology. 2014; 122(4):748-54. PMC: 4994530. DOI: 10.1016/j.ophtha.2014.11.001. View

17.

Zemba M, Stamate A, Tataru C, Branisteanu D, Balta F . Conjunctival flap surgery in the management of ocular surface disease (Review). Exp Ther Med. 2020; 20(4):3412-3416. PMC: 7465514. DOI: 10.3892/etm.2020.8964. View

18.

Friedman D, Jampel H, Congdon N, Miller R, Quigley H . The TRAVATAN Dosing Aid accurately records when drops are taken. Am J Ophthalmol. 2007; 143(4):699-701. DOI: 10.1016/j.ajo.2006.11.036. View

19.

Wolfram C, Stahlberg E, Pfeiffer N . Patient-Reported Nonadherence with Glaucoma Therapy. J Ocul Pharmacol Ther. 2019; 35(4):223-228. PMC: 6533777. DOI: 10.1089/jop.2018.0134. View

20.

Vlieland N, van den Bemt B, Bekker C, Bouvy M, Egberts T, Gardarsdottir H . Older Patients' Compliance with Drug Storage Recommendations. Drugs Aging. 2018; 35(3):233-241. PMC: 5884895. DOI: 10.1007/s40266-018-0524-8. View